{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:06:14Z","timestamp":1787807174858,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0274-8","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T01:45:33Z","timestamp":1466041533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of low-dose aspirin in subjects with dyslipidemia"],"prefix":"10.1186","volume":"15","author":[{"given":"Guozhong","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"274_CR1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Antithrombotic Trialists","year":"2009","unstructured":"Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849\u201360.","journal-title":"Lancet"},{"key":"274_CR2","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/jama.2015.13919","volume":"314","author":"J Rodes-Cabau","year":"2015","unstructured":"Rodes-Cabau J, Horlick E, Ibrahim R, Cheema AN, Labinaz M, Nadeem N, Osten M, Cote M, Marsal JR, Rivest D, Marrero A, Houde C. Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: The canoa randomized clinical trial. Jama. 2015;314:2147\u201354.","journal-title":"Jama"},{"key":"274_CR3","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1001\/jama.2014.15690","volume":"312","author":"Y Ikeda","year":"2014","unstructured":"Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N. Low-dose aspirin for primary prevention of cardiovascular events in japanese patients 60\u00a0years or older with atherosclerotic risk factors: A randomized clinical trial. Jama. 2014;312:2510\u201320.","journal-title":"Jama"},{"key":"274_CR4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2796.2003.01135.x","volume":"253","author":"B Jonsson","year":"2003","unstructured":"Jonsson B, Hansson L, Stalhammar NO. Health economics in the hypertension optimal treatment (hot) study: Costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. J Intern Med. 2003;253:472\u201380.","journal-title":"J Intern Med"},{"key":"274_CR5","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","volume":"300","author":"H Ogawa","year":"2008","unstructured":"Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y. Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes Trial I. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial. Jama. 2008;300:2134\u201341.","journal-title":"Jama"},{"key":"274_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","volume":"321","author":"Final report on the aspirin component of the ongoing physicians' health study","year":"1989","unstructured":"Final report on the aspirin component of the ongoing physicians' health study. Steering committee of the physicians' health study research group. N Engl J Med. 1989;321:129\u201335.","journal-title":"N Engl J Med"},{"key":"274_CR7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293\u2013304.","journal-title":"N Engl J Med"},{"key":"274_CR8","doi-asserted-by":"crossref","first-page":"e98326","DOI":"10.1371\/journal.pone.0098326","volume":"9","author":"IC Wu","year":"2014","unstructured":"Wu IC, Lin MY, Yu FJ, Hsieh HM, Chiu KF, Wu MT. A short-term effect of low-dose aspirin on major hemorrhagic risks in primary prevention: A case-crossover design. PLoS One. 2014;9:e98326.","journal-title":"PLoS One"},{"key":"274_CR9","first-page":"19200","volume":"8","author":"PJ Liao","year":"2015","unstructured":"Liao PJ, Xie RB, Yin RX, Wei DX, Huang J, Huang F, Li H, Lin WX, Wu JZ, Pan SL. Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated chinese minorities. Int J Clin Exp Med. 2015;8:19200\u201311.","journal-title":"Int J Clin Exp Med"},{"key":"274_CR10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","volume":"279","author":"JR Downs","year":"1998","unstructured":"Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto Jr AM. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of afcaps\/texcaps. Air force\/texas coronary atherosclerosis prevention study. Jama. 1998;279:1615\u201322.","journal-title":"Jama"},{"key":"274_CR11","doi-asserted-by":"crossref","first-page":"e000342","DOI":"10.1136\/openhrt-2015-000342","volume":"3","author":"J Watt","year":"2016","unstructured":"Watt J, Kennedy S, Ahmed N, Hayhurst J, McClure JD, Berry C, Wadsworth RM, Oldroyd KG. The relationship between oxidised ldl, endothelial progenitor cells and coronary endothelial function in patients with chd. Open Heart. 2016;3:e000342.","journal-title":"Open Heart"},{"key":"274_CR12","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2006.03.034","volume":"47","author":"BM Scirica","year":"2006","unstructured":"Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, McCabe CH, Braunwald E, PI-T Investigators. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the prove it-timi 22 study. J Am Coll Cardiol. 2006;47:2326\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"274_CR13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2015.11.052","volume":"67","author":"R Ramos","year":"2016","unstructured":"Ramos R, Garcia-Gil M, Comas-Cufi M, Quesada M, Marrugat J, Elosua R, Sala J, Grau M, Marti R, Ponjoan A, Alves-Cabratosa L, Blanch J, Bolibar B. Statins for prevention of cardiovascular events in a low-risk population with low ankle brachial index. J Am Coll Cardiol. 2016;67:630\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"274_CR14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","volume":"32","author":"G Parati","year":"2014","unstructured":"Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y, European Society of Hypertension Working Group on Blood Pressure M, Cardiovascular V. European society of hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359\u201366.","journal-title":"J Hypertens"},{"key":"274_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/diaclin.33.2.97","volume":"33","author":"American Diabetes A","year":"2015","unstructured":"American Diabetes A. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diab. 2015;33:97\u2013111.","journal-title":"Clin Diab"},{"key":"274_CR16","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.amjcard.2011.02.325","volume":"107","author":"AA Bartolucci","year":"2011","unstructured":"Bartolucci AA, Tendera M, Howard G. Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol. 2011;107:1796\u2013801.","journal-title":"Am J Cardiol"},{"key":"274_CR17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.12659\/MSM.892271","volume":"20","author":"H Tao","year":"2014","unstructured":"Tao H, Wang Y, Zhou X, Zhong W, Zhou H, Li K, Zhao B. Angiographic correlation and synergistic effect of coronary artery stenosis and cerebral artery stenosis: A retrospective study. Med Sci Monit. 2014;20:1902\u20137.","journal-title":"Med Sci Monit"},{"key":"274_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1532-5415.2006.01018.x","volume":"55","author":"DA Rhoades","year":"2007","unstructured":"Rhoades DA, Welty TK, Wang W, Yeh F, Devereux RB, Fabsitz RR, Lee ET, Howard BV. Aging and the prevalence of cardiovascular disease risk factors in older american indians: The strong heart study. J Am Geriatr Soc. 2007;55:87\u201394.","journal-title":"J Am Geriatr Soc"},{"key":"274_CR19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1586\/17474124.2015.1095089","volume":"9","author":"M Miftahussurur","year":"2015","unstructured":"Miftahussurur M, Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2015;9:1535\u201347.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"274_CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0004-28032015000100010","volume":"52","author":"DM Carli","year":"2015","unstructured":"Carli DM, Pires RC, Rohde SL, Kavalco CM, Fagundes RB. Peptic ulcer frequency differences related to h. Pylori or aines. Arq Gastroenterol. 2015;52:46\u20139.","journal-title":"Arq Gastroenterol"},{"key":"274_CR21","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4049\/jimmunol.1500021","volume":"196","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu WK, Gallo RL, Fang EF, Hu W, Ling TK, Shen J, Chan RL, Lu L, Luo XM, Li MX, Chan KM, Yu J, Wong VW, Ng SC, Wong SH, Chan FK, Sung JJ, Chan MT, Cho CH. Critical role of antimicrobial peptide cathelicidin for controlling helicobacter pylori survival and infection. J Immunol. 2016;196:1799\u2013809.","journal-title":"J Immunol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0274-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:27:34Z","timestamp":1498307254000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0274-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]},"article-number":"106"}}